A 70-year-old Japanese woman was admitted to our hospital for the treatment of pulmonary MAC infection. She had a history of symptomatic epilepsy due to the cerebral arteriovenous 
metabolizing enzymes and P-gp. As mentioned above, when drugs that have opposite pharmacokinetic effects are used in combination, it is necessary to pay attention to changes in their pharmacokinetics and pharmacological effects. Drug-drug interactions (DDIs) between RFP and CAM have been reported previously, and concomitant use of RFP decreased the area under the curve (AUC) and Cmax of CAM. 4, 5 Here, we report a case of a patient in whom effective chemotherapy was complicated by DDIs among drugs prescribed for MAC infection and epilepsy. Repeated therapeutic drug monitoring (TDM) was required for appropriate dose adjustment.
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Summary
What is known and objective: Multi-drug combinations often make chemotherapy difficult owing to drug-drug interactions (DDIs). We report a rare and difficult-totreat case due to DDIs between drugs for Mycobacterium avium complex (MAC) infection and antiepileptic drugs.
Case description:
A 70-year-old Japanese woman was diagnosed as having pulmonary MAC disease. She had a history of symptomatic epilepsy, which was successfully treated with phenytoin and phenobarbital. Serum phenytoin concentrations increased upon the initiation of MAC infection treatment.
What is new and Conclusion:
We evaluated DDIs and adjusted the dosage of drugs by monitoring the serum drug level.
K E Y W O R D S
clarithromycin, drug-drug interaction, phenytoin, rifampicin, therapeutic drug monitoring aneurysm. Before treatment of pulmonary MAC infection, she received a prescription of l-glutamine, propranolol, candesartan, benidipine, pravastatin, phenytoin and phenobarbital.
The serum trough concentrations of phenytoin (225 mg/day) and phenobarbital (75 mg/day) on admission were 6.45 and 11.27 μg/mL, respectively. The treatment regimen of pulmonary MAC disease, which comprised RFP (300 mg/day), EB (625 mg/ day) and CAM (800 mg/day), was initiated on the second day of hospitalization. Since the serum concentrations of phenytoin and phenobarbital were anticipated to be influenced by the treatment of pulmonary MAC disease, we performed TDM sequentially. Table 1 shows the DDIs associated with the cytochrome P450 (CYP) family and P-gp, among the drugs that were being administered. Serum phenytoin concentrations increased upon the initiation of pulmonary MAC disease treatment (Figure 1 ). Since phenytoin is a substrate of CYP 2C19, 2C9 and P-gp, serum phenytoin concentration was expected to decrease with the addition of RFP. However, serum phenytoin concentration showed a remarkable increase compared with that before MAC treatment. P-gp inhibition by CAM is considered to contribute significantly to phenytoin pharmacokinetics. Schinkel et al reported that phenytoin is transported not only by passive diffusion, but also by P-gp. 6 It has been reported that RFP, phenobarbital and phenytoin induce P-gp and CYP via the same mechanism that involves activation of the nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR). 7, 8 CYP and P-gp were thought to be sufficiently induced by phenobarbital and phenytoin, which were administered before the initiation of MAC treatment. Moreover, the addition of RFP might have had a minor effect on CYP and P-gp induction, resulting in a decrease in serum phenytoin concentration. Benidipine and propranolol are substrates of CYP3A4 and 2C19, respectively, and therefore, the induction of CYP3A4 and 2C19 due to the addition of RFP was predicted to increase blood pressure; however, no significant effect was observed. RFP might not upregulate the expression of CYP and P-gp, which had already been induced by phenobarbital and phenytoin. CAM addition was thought to suppress the activity of P-gp. 
| WHAT IS NE W AND CON CLUS I ON

ACK N OWLED G EM ENTS
We would like to thank Editage (www.editage.jp) for English language editing.
CO N FLI C T S O F I NTE R E S T
